← Back to All US Stocks

Aditxt, Inc. (ADTX) Fundamental Analysis & AI Grade 2026

ADTX Nasdaq Pharmaceutical Preparations DE CIK: 0001726711
Updated This Month • Analysis: May 23, 2026 • SEC Data: 2026-03-31
Combined AI Grade
D
98% Confidence
STRONG AGREEMENT
D
98% Conf
D
97% Conf

📊 ADTX Key Takeaways

Revenue: $12.2K
Net Margin: -131,159.8%
Free Cash Flow: $-4.6M
Current Ratio: 0.06x
Debt/Equity: N/A
EPS: $-790.49
AI Grade: D with 98% confidence
Aditxt, Inc. (ADTX) receives a D fundamental grade with 98% confidence from our AI analysis based on SEC 10-K filings. With revenue of $12.2K, net profit margin of -131,159.8%, Aditxt, Inc. demonstrates mixed fundamentals in the Healthcare sector. Below is our complete ADTX stock analysis for 2026.

Is Aditxt, Inc. (ADTX) a Good Investment?

Claude

Aditxt faces imminent financial distress with negative stockholders equity of -$33.3M, liabilities exceeding assets by $35.2M, and critically depleted cash reserves of $268.9K supporting -$4.6M annual operating cash burn. Revenue has collapsed 97.6% YoY to $12.2K with no evidence of operational recovery, leaving the company technically insolvent with an estimated 2-3 months of cash runway at current burn rates.

ChatGPT

Aditxt’s fundamentals are severely impaired: revenue is negligible, margins are deeply negative, and the business is consuming far more cash than it generates. With only $163K of cash, a 0.02x current ratio, and negative stockholders’ equity, the company’s near-term financial health appears highly stressed and its growth quality is extremely weak.

Aditxt, Inc. Key Strengths (ADTX)

Claude
  • + Positive gross margin of 23.6% on products suggests underlying unit economics may exist if revenue can be restored
  • + Total assets of $13.9M provide some liquidation value
  • + Moderate insider activity (2 Form 4 filings in 90 days) suggests limited insider panic selling
ChatGPT
  • + Net loss improved year over year, indicating losses narrowed from the prior period
  • + Capital expenditure is minimal, so cash burn is not being driven by heavy fixed-asset spending
  • + The company still retains an asset base of $11.8M that could support ongoing operations or restructuring efforts

ADTX Stock Risks: Aditxt, Inc. Investment Risks

Claude
  • ! Negative stockholders equity of -$33.3M indicates technical insolvency and company is balance-sheet underwater
  • ! Severe liquidity crisis with 0.06x current ratio and only $268.9K cash against operating cash burn of -$4.6M annually
  • ! Revenue collapse of 97.6% YoY to $12.2K indicates loss of core business operations with no visible path to recovery
  • ! Liabilities exceed assets by $35.2M requiring significant debt restructuring, dilution, or bankruptcy proceeding
  • ! Estimated 2-3 months of cash runway suggests high probability of financing distress, default, or bankruptcy filing
  • ! Long-term debt of $3.1M at risk given negative cash flows and insolvency status
ChatGPT
  • ! Liquidity is critically weak, with just $163K of cash and a 0.02x current ratio
  • ! Revenue base is extremely small and declined 79.2% year over year, raising major questions about commercial viability
  • ! Negative equity and large operating and free cash flow losses indicate a highly fragile balance sheet and funding dependence

Key Metrics to Watch

Claude
  • * Cash balance trend and monthly burn rate (survival metric)
  • * Revenue stabilization or recovery toward historical levels
  • * Debt restructuring negotiations or refinancing announcements
  • * Operating cash flow inflection point to positive territory
  • * Equity dilution, capital raises, or strategic asset sales
  • * Bankruptcy filing risk or going-concern disclosures in SEC filings
ChatGPT
  • * Quarterly revenue growth and gross margin improvement
  • * Cash balance relative to operating cash burn and current liabilities

Aditxt, Inc. (ADTX) Financial Metrics & Key Ratios

Revenue
$12.2K
Net Income
$-15.9M
EPS (Diluted)
$-790.49
Free Cash Flow
$-4.6M
Total Assets
$13.9M
Cash Position
$268.9K

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

ADTX Profit Margin, ROE & Profitability Analysis

Gross Margin 23.6%
Operating Margin -35,873.5%
Net Margin -131,159.8%
ROE N/A
ROA -114.7%
FCF Margin -37,742.3%

ADTX vs Healthcare Sector: How Aditxt, Inc. Compares

How Aditxt, Inc. compares to Healthcare sector averages

Net Margin
ADTX -131,159.8%
vs
Sector Avg 12.0%
ADTX Sector
ROE
ADTX 0.0%
vs
Sector Avg 15.0%
ADTX Sector
Current Ratio
ADTX 0.1x
vs
Sector Avg 2.0x
ADTX Sector
Debt/Equity
ADTX 0.0x
vs
Sector Avg 0.6x
ADTX Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Aditxt, Inc. Stock Overvalued? ADTX Valuation Analysis 2026

Based on fundamental analysis, Aditxt, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
N/A
Sector avg: 15%
Net Profit Margin
-131,159.8%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
N/A
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Aditxt, Inc. Balance Sheet: ADTX Debt, Cash & Liquidity

Current Ratio
0.06x
Quick Ratio
0.05x
Debt/Equity
N/A
Debt/Assets
352.9%
Interest Coverage
N/A
Long-term Debt
$3.1M

ADTX Revenue & Earnings Growth: 5-Year Financial Trend

ADTX 5-year financial data: Year 2021: Revenue $105.0K, Net Income -$9.1M, EPS N/A. Year 2022: Revenue $933.7K, Net Income -$46.4M, EPS $-121.18. Year 2023: Revenue $933.7K, Net Income -$27.6M, EPS $-595.60. Year 2024: Revenue $645.2K, Net Income -$32.7M, EPS $-27,038.26. Year 2025: Revenue $134.0K, Net Income -$40.4M, EPS $-22,147,415.22.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Aditxt, Inc.'s revenue has grown significantly by 28% over the 5-year period, indicating strong business expansion. The most recent EPS of $-22,147,415.22 indicates the company is currently unprofitable.

ADTX Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-37,742.3%
Free cash flow / Revenue

ADTX Quarterly Earnings & Performance

Quarterly financial performance data for Aditxt, Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q1 2026 $1.0K -$5.7M $-790.49
Q3 2025 $748 -$12.8M $-548.78
Q2 2025 $1.0K -$7.3M $-3.45
Q1 2025 $1.0K -$5.7M $-8.12
Q3 2024 $6.9K -$9.9M $-111.07
Q2 2024 $44.3K -$5.7M $-4.19
Q1 2024 $79.7K -$6.0M $-9.21
Q3 2023 $124.5K -$5.7M $-47.95

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

Aditxt, Inc. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
-$4.6M
Cash generated from operations
Capital Expenditures
$10.4K
Investment in assets
Dividends
None
No dividend program

ADTX SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Aditxt, Inc. (CIK: 0001726711)

📋 Recent SEC Filings

Date Form Document Action
Jun 9, 2026 8-K ea0293812-8k_aditxt.htm View →
Jun 8, 2026 4 xslF345X06/primary_doc.xml View →
Jun 5, 2026 8-K ea0293649-8k_aditxt.htm View →
Jun 1, 2026 8-K ea0292902-8k_aditxt.htm View →
May 29, 2026 8-K ea0292786-8k_aditxt.htm View →

Frequently Asked Questions about ADTX

What is the AI rating for ADTX?

Aditxt, Inc. (ADTX) has a Combined AI Grade of D from Claude (D) and ChatGPT (D) with 98% combined confidence, based on fundamental analysis of SEC EDGAR filings.

What are ADTX's key strengths?

Claude: Positive gross margin of 23.6% on products suggests underlying unit economics may exist if revenue can be restored. Total assets of $13.9M provide some liquidation value. ChatGPT: Net loss improved year over year, indicating losses narrowed from the prior period. Capital expenditure is minimal, so cash burn is not being driven by heavy fixed-asset spending.

What are the risks of investing in ADTX?

Claude: Negative stockholders equity of -$33.3M indicates technical insolvency and company is balance-sheet underwater. Severe liquidity crisis with 0.06x current ratio and only $268.9K cash against operating cash burn of -$4.6M annually. ChatGPT: Liquidity is critically weak, with just $163K of cash and a 0.02x current ratio. Revenue base is extremely small and declined 79.2% year over year, raising major questions about commercial viability.

What is ADTX's revenue and growth?

Aditxt, Inc. reported revenue of $12.2K.

Does ADTX pay dividends?

Aditxt, Inc. does not currently pay dividends.

Where can I find ADTX SEC filings?

Official SEC filings for Aditxt, Inc. (CIK: 0001726711) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is ADTX's EPS?

Aditxt, Inc. has a diluted EPS of $-790.49.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.

What is ADTX's fundamental grade?

Based on our AI fundamental analysis in June 2026, Aditxt, Inc. has a D grade with 98% confidence. Review the strengths and risks sections above for full context. This is not investment advice.

Is ADTX stock overvalued or undervalued?

Valuation metrics for ADTX: ROE of N/A (sector avg: 15%), net margin of -131,159.8% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

What is ADTX's AI grade for 2026?

Our dual AI analysis gives Aditxt, Inc. a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is ADTX's free cash flow?

Aditxt, Inc.'s operating cash flow is $-4.6M, with capital expenditures of $10.4K. FCF margin is -37,742.3%.

How does ADTX compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin -131,159.8% (avg: 12%), ROE N/A (avg: 15%), current ratio 0.06 (avg: 2).

Top Rated Stocks
AAPL 92% MSFT 92% FAST 92% ANET 88% RDDT 88% KNSL 88% MGRE 88% FIZZ 88% AVGO 87% DECK 87%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: May 23, 2026 | Data as of: 2026-03-31 | Powered by Claude AI